The preamble also describes the seven alternatives considered by FDA in promulgating this rule and why it believes that the alternative selected ( the mammalian-to-ruminant prohibition--with exceptions ) is the most cost-effective regulatory alternative that meets the objective of the agency .
The preamble describes less than 8 alternative considered by the FDA .